Peter L. Salgo, MD: We’re going to be talking about anemia here. What percentage of the chronic kidney disease [CKD] population gets anemic, and what is the etiology of the anemia? Robert Provenzano, ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Well, the first step is diagnosis. We have ...

Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...

Underuse of erythropoiesis-stimulating agents (ESA) and ESA hyporesponsiveness are 2 important reasons for red blood cell transfusion, according to a recent review. It is difficult to avoid the use of ...

Oral vadadustat, one of a new class of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), is effective in the treatment of anemia in people with chronic kidney disease (CKD), but ...

There are several that your doctor can order to figure out if you have anemia. They can include: Complete blood count. You might have heard of this test called a CBC. It takes just a few minutes and ...

A new study used German data to assess the effects of CKD, anemia, or both on the development and eventual progression of HF among at-risk and symptomatic patients. The prevalence and severity of CKD ...

Renal transplant patients with elevated phosphorus had lower Hb levels. Higher serum phosphorus levels are associated with lower blood hemoglobin (Hb) levels and a greater likelihood of anemia in ...

We observed that anemia and chronic kidney disease are two frequent conditions among stroke patients. Anemia was independently associated with a decreased one-year survival. Although GFR was ...

Anemia of chronic disease is anemia caused by inflammation from a long-term or chronic illness. It is also called anemia of inflammation. People with anemia of chronic disease may have normal or even ...

Akebia Therapeutics, Inc. AKBA announced that the FDA has approved its Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD). The eligible patient population for ...